- Home
- CDNA vs AVAH Comparison
CDNA vs AVAH Comparison
Compare CDNA & AVAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- AVAH
- Stock Information
- Founded
- CDNA 1998
- AVAH 1984
- Country
- CDNA United States
- AVAH United States
- Employees
- CDNA N/A
- AVAH N/A
- Industry
- CDNA Medical Specialities
- AVAH Hospital/Nursing Management
- Sector
- CDNA Health Care
- AVAH Health Care
- Exchange
- CDNA Nasdaq
- AVAH Nasdaq
- Market Cap
- CDNA 1.1B
- AVAH 927.5M
- IPO Year
- CDNA 2014
- AVAH 2021
- Fundamental
- Price
- CDNA $22.94
- AVAH $4.72
- Analyst Decision
- CDNA Buy
- AVAH Hold
- Analyst Count
- CDNA 8
- AVAH 4
- Target Price
- CDNA $26.43
- AVAH $4.51
- AVG Volume (30 Days)
- CDNA 823.5K
- AVAH 169.2K
- Earning Date
- CDNA 02-26-2025
- AVAH 03-13-2025
- Dividend Yield
- CDNA N/A
- AVAH N/A
- EPS Growth
- CDNA N/A
- AVAH N/A
- EPS
- CDNA N/A
- AVAH N/A
- Revenue
- CDNA $312,775,000.00
- AVAH $1,983,475,000.00
- Revenue This Year
- CDNA $20.27
- AVAH $7.85
- Revenue Next Year
- CDNA $11.76
- AVAH $5.09
- P/E Ratio
- CDNA N/A
- AVAH N/A
- Revenue Growth
- CDNA 5.26
- AVAH 6.21
- 52 Week Low
- CDNA $7.42
- AVAH $2.00
- 52 Week High
- CDNA $34.84
- AVAH $6.19
- Technical
- Relative Strength Index (RSI)
- CDNA 53.43
- AVAH 44.28
- Support Level
- CDNA $21.96
- AVAH $4.74
- Resistance Level
- CDNA $23.80
- AVAH $5.00
- Average True Range (ATR)
- CDNA 1.53
- AVAH 0.21
- MACD
- CDNA 0.09
- AVAH 0.01
- Stochastic Oscillator
- CDNA 45.88
- AVAH 41.54
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.
About AVAH Aveanna Healthcare Holdings Inc.
Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). Private Duty Services include private duty nursing (PDN) and pediatric therapy services. Revenue is primarily derived from pediatric healthcare services provided to patients including private duty nursing and therapy services, adult home health and hospice services (collectively patient revenue) and from the delivery of enteral nutrition and other products to patients.